Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.08% Nasdaq Down0.83%

Organovo Holdings, Inc. (ONVO)

6.32 Down 0.34(5.11%) 4:00PM EDT
|After Hours : 6.32 0.00 (0.00%) 5:33PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
ProfileGet Profile for:
Organovo Holdings, Inc.
5871 Oberlin Drive
Suite 150
San Diego, CA 92121
United States - Map
Phone: 858-550-9994

Index Membership:N/A
Industry:Medical Laboratories & Research
Full Time Employees:39

Business Summary 

Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company’s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern. It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development. The company was founded in 2007 and is based in San Diego, California.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Organovo Holdings, Inc.

Key Executives 
Mr. Keith Murphy , 42
Chairman and Chief Exec. Officer
Mr. Barry D. Michaels , 64
Chief Financial Officer and Sec.
Dr. Sharon Collins Presnell Ph.D., 45
Chief Technology Officer and Exec. VP of R&D
Mr. Michael Renard , 55
Exec. VP of Commercial Operations
Dr. Eric Michael David M.D., J.D., Ph.D., 42
Chief Strategy Officer
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders